Augmentation of anti-HLA-E antibodies with concomitant HLA-Ia reactivity in IFNγ-treated autologous melanoma cell vaccine recipients*

By Ravindranath Mepur H.   Selvan Senthamil R.   Terasaki Paul I.  

Journal of Immunotoxicology, Vol. 9, Iss. 3, 2012-09 ,pp. : 282-291

Informa Healthcare

Access to resources Recommend Favorite

Generation of tumour-rejecting anti-carbohydrate monoclonal antibodies using melanoma modified with Fas ligand

By Simon A. Katharina   Newsom-Davis Tom   Frayne Matthew E. F.   Chen Paul F.-T.   McMichael Andrew J.   Screaton Gavin R.  

International Immunology, Vol. 20, Iss. 4, 2008-04 ,pp. : 525-534

Oxford University Press

Access to resources Recommend Favorite

Augmentation of IgM Antibody to gp43 Tumor-Associated Antigen Peptide by Melanoma Cell Vaccine

By Takahashi Takenori   Conforti Arnold   Kikumoto Yoshikazu   Hoon Dave S. B.   Morton Donald L.   Irie Reiko F.  

Journal of Clinical Immunology, Vol. 18, Iss. 4, 1998-07 ,pp. : 299-305

Springer Publishing Company

Access to resources Recommend Favorite

CD40 expressed on human melanoma cells mediates T cell co-stimulation and tumor cell growth

By Zanzi D.  

International Immunology, Vol. 12, Iss. 6, 2000-06 ,pp. : 787-795

Oxford University Press

Access to resources Recommend Favorite

Autologous Hsp70 Induces Antigen Specific Th1 Immune Responses in a Murine T-Cell Lymphoma

By Kumar Sanjay   Deepak Praveen   Kumar Sanjay   Kishore Dhiraj   Acharya Arbind  

Immunological Investigations, Vol. 38, Iss. 6, 2009-08 ,pp. : 449-465

Informa Healthcare

Access to resources Recommend Favorite